Search

everythinglearnresearchcommunity

for

Search:↓

Surgery, especially prostatectomy, effectively reduces detrusor overactivity in bladder outlet obstruction patients.

Combination therapy is more effective for prostate volumes over 60 ml.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Uterine transplants for transgender women are feasible but need more research.

BPH treatments can cause sexual side effects affecting quality of life.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Sonirid Duo effectively treats benign prostatic hyperplasia.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.